Pharming Group reports financial results for the first quart

FDA approval and commercial launch of Joenja® (leniolisib) in the U.S. Joenja® launch off to strong start with 23 U.S. patients on paid therapy Revenues...

Related Keywords

Japan , London , City Of , United Kingdom , Amsterdam , Noord Holland , Netherlands , Australia , Canada , United States , America , Japanese , Michael Levitan , Heather Robertson , Foster Mitchell Alex Shaw , Pharming Group , Vp Investor Relations Corporate Communications , Linkedin , Ministry Of Health , Pharming Groupnv , Exchange Commission , European Medicines Agency , Silicon Valley Bank , Novartis , Company Euronext , Nasdaq , European Commission Decision Reliance Procedure , Lifespring Life Sciences Communication , Investor Relations Corporate Communications , Drug Administration , Regulatory Agency , Committee For Human Medicinal Products , Executive Officer , Sijmen De Vries , New Drug Application , Human Medicinal Products , Marketing Authorisation Application , Orphan Drug Designation , Pediatric Investigational Plan , Investigational New Drug , Silicon Valley , Marketing Authorisation , General Meeting , Shareholders May , Investor Relations , Corporate Communications , Spring Life Sciences Communication , North America , Middle East , Annual Report , Consolidated Interim Financial Statements , Consolidated Statement , Comprehensive Income ,